Wells Fargo & Company Organovo Holdings, Inc. Transaction History
Wells Fargo & Company
- $433 Billion
- Q4 2024
A detailed history of Wells Fargo & Company transactions in Organovo Holdings, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 1,842 shares of ONVO stock, worth $699. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,842
Previous 397
363.98%
Holding current value
$699
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding ONVO
# of Institutions
34Shares Held
2.51MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY1.64MShares$622,6850.01% of portfolio
-
Prescott Group Capital Management, L.L.C. Tulsa, OK281KShares$106,5940.01% of portfolio
-
Black Rock Inc. New York, NY142KShares$54,0390.0% of portfolio
-
Geode Capital Management, LLC Boston, MA121KShares$45,8020.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA115KShares$43,5630.0% of portfolio
About ORGANOVO HOLDINGS, INC.
- Ticker ONVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,712,020
- Market Cap $3.31M
- Description
- Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparin...